These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21897365)

  • 1. Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis.
    Yilmaz M; Maass D; Tiwari N; Waldmeier L; Schmidt P; Lehembre F; Christofori G
    EMBO J; 2011 Sep; 30(21):4489-99. PubMed ID: 21897365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
    Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
    BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signaling.
    Truty MJ; Lomberk G; Fernandez-Zapico ME; Urrutia R
    J Biol Chem; 2009 Mar; 284(10):6291-300. PubMed ID: 19088080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
    Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
    Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus.
    Jiang B; Zhang JS; Du J; Urrutia R; Barnard J
    Cell Signal; 2003 Jul; 15(7):699-708. PubMed ID: 12742230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
    Liu IM; Schilling SH; Knouse KA; Choy L; Derynck R; Wang XF
    EMBO J; 2009 Jan; 28(2):88-98. PubMed ID: 19096363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway.
    Lee IH; Sohn M; Lim HJ; Yoon S; Oh H; Shin S; Shin JH; Oh SH; Kim J; Lee DK; Noh DY; Bae DS; Seong JK; Bae YS
    Oncogene; 2014 Sep; 33(38):4675-84. PubMed ID: 24662814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.
    Cohen J; Chen Z; Lu SL; Yang XP; Arun P; Ehsanian R; Brown MS; Lu H; Yan B; Diallo O; Wang XJ; Van Waes C
    Cancer Res; 2009 Apr; 69(8):3415-24. PubMed ID: 19351843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
    Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
    Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype.
    Bharathy S; Xie W; Yingling JM; Reiss M
    Cancer Res; 2008 Mar; 68(6):1656-66. PubMed ID: 18339844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.
    de Figueiredo-Pontes LL; Assis PA; Santana-Lemos BA; Jácomo RH; Lima AS; Garcia AB; Thomé CH; Araújo AG; Panepucci RA; Zago MA; Nagler A; Falcão RP; Rego EM
    PLoS One; 2011; 6(10):e26713. PubMed ID: 22053203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
    Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
    PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
    Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
    Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
    Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
    Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
    Jin Q; Gao G; Mulder KM
    J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.
    Wimmel A; Wiedenmann B; Rosewicz S
    Gut; 2003 Sep; 52(9):1308-16. PubMed ID: 12912863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.